← Back to Clinical Trials
Recruiting NCT06455137

NCT06455137 Epidural Electrical Stimulation for Spinal Cord Injury Patients and Corticospinal Motor Circuit Improvement

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06455137
Status Recruiting
Phase
Sponsor Buddhist Tzu Chi General Hospital
Condition Spinal Cord Injuries
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2024-04-30
Primary Completion 2026-12-31

Trial Parameters

Condition Spinal Cord Injuries
Sponsor Buddhist Tzu Chi General Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 20
Sex ALL
Min Age 20 Years
Max Age 70 Years
Start Date 2024-04-30
Completion 2026-12-31
Interventions
Epidural Stimulator

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The study aims to examine the plausible interventional mechanisms underlying the effects of epidural spinal cord stimulation.

Eligibility Criteria

Inclusion Criteria: * SCI ASIA: A, B, C,D * Between 20 and 70 year of age * \>1 year post SCI * Complete or incomplete spinal cord injury. * Expected will undergo spinal cord stimulation surgery. * Continued rehabilitation after surgery for spinal cord injury. * Able to comply with procedures and follow up. * Stable medical condition without cardiopulmonary disease or dysautonomia that would - contraindicate participation in lower extremity rehabilitation or testing activities Exclusion Criteria: * Have significant cognitive impairment (MMSE\<24). * Had a mental illness within one year or been treated in the past. * Have Major depressive disorder. * Active cancer diagnosis. * Painful musculoskeletal dysfunction, unhealed fracture, contracture, pressure sore, or urinary tract infection that might interfere with stand or step training. * Cardiovascular or musculoskeletal disease or injury that would prevent full participation in physical therapy intervention. * Unable to read and/or comp

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology